[go: up one dir, main page]

GB1113760A - Ophthalmic composition - Google Patents

Ophthalmic composition

Info

Publication number
GB1113760A
GB1113760A GB56491/66A GB5649166A GB1113760A GB 1113760 A GB1113760 A GB 1113760A GB 56491/66 A GB56491/66 A GB 56491/66A GB 5649166 A GB5649166 A GB 5649166A GB 1113760 A GB1113760 A GB 1113760A
Authority
GB
United Kingdom
Prior art keywords
weight
composition
agent
toxic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB56491/66A
Inventor
Joseph Zenon Krezanoski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barnes Hind Diagnostics Inc
Original Assignee
Barnes Hind Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barnes Hind Diagnostics Inc filed Critical Barnes Hind Diagnostics Inc
Priority to GB56491/66A priority Critical patent/GB1113760A/en
Priority to AU15852/66A priority patent/AU412212B2/en
Publication of GB1113760A publication Critical patent/GB1113760A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ophthalmic compositions, particularly for use with an applanation tonometer and in the location of foreign bodies in the eye, comprise (a), as local anaesthetic, 0.1 to 2% by weight of proparacaine, parethoxycaine, benoxinate, or tetracaine (in the form of a non-toxic, water-soluble salt, e.g. hydrochloride), (b) as disclosing agent, 0.05% to 0.3% by weight of fluorescein sodium and (c) 5 to 15% by weight of polyvinylpyrrolidone as complexing and solubilizing agent, the percentages being based on the total weight of the composition, and the balance of the composition being water and a non-toxic acid to bring the pH of the composition to 4.5 to 5.5. The non-toxic acid may be citric or preferably boric acid. The compositions may also contain an antimicrobial agent (e.g. chlorobutanol \sB phenyl mercuric acetate) and a chelating agent (e.g. disodium ethylene diamine tetra acetic acid).
GB56491/66A 1966-12-16 1966-12-16 Ophthalmic composition Expired GB1113760A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB56491/66A GB1113760A (en) 1966-12-16 1966-12-16 Ophthalmic composition
AU15852/66A AU412212B2 (en) 1966-12-16 1966-12-29 Ophthalmic composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB56491/66A GB1113760A (en) 1966-12-16 1966-12-16 Ophthalmic composition
AU15852/66A AU412212B2 (en) 1966-12-16 1966-12-29 Ophthalmic composition

Publications (1)

Publication Number Publication Date
GB1113760A true GB1113760A (en) 1968-05-15

Family

ID=74187404

Family Applications (1)

Application Number Title Priority Date Filing Date
GB56491/66A Expired GB1113760A (en) 1966-12-16 1966-12-16 Ophthalmic composition

Country Status (2)

Country Link
AU (1) AU412212B2 (en)
GB (1) GB1113760A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000190A1 (en) * 1977-07-01 1979-01-10 Dr. Karl Thomae GmbH Solutions with a local anesthetic effect.
EP1027015A4 (en) * 1997-03-18 2001-06-27 Miles A Galin CONTROLLED DELIVERY OF PHARMACEUTICALS IN THE FRONT EYE
GB2434446A (en) * 2006-01-25 2007-07-25 Pentax Corp Method for fluorescently staining tissue
US8298514B2 (en) 2006-06-15 2012-10-30 Hoya Corporation Agent for enhancing contrast of image of fluorescent staining of lumen of digestive tract

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000190A1 (en) * 1977-07-01 1979-01-10 Dr. Karl Thomae GmbH Solutions with a local anesthetic effect.
EP1027015A4 (en) * 1997-03-18 2001-06-27 Miles A Galin CONTROLLED DELIVERY OF PHARMACEUTICALS IN THE FRONT EYE
GB2434446A (en) * 2006-01-25 2007-07-25 Pentax Corp Method for fluorescently staining tissue
GB2434446B (en) * 2006-01-25 2010-09-01 Pentax Corp Method for fluorescently staining tissue
DE102007003873B4 (en) * 2006-01-25 2015-08-06 Hoya Corp. Method for fluorescence staining and examination of tissue
US8298514B2 (en) 2006-06-15 2012-10-30 Hoya Corporation Agent for enhancing contrast of image of fluorescent staining of lumen of digestive tract

Also Published As

Publication number Publication date
AU1585266A (en) 1968-07-04
AU412212B2 (en) 1971-04-06

Similar Documents

Publication Publication Date Title
FI951266A0 (en) Germicidal detergent iodine compositions with reduced detergent content
RU2013129222A (en) EYE COMPOSITIONS CONCERNING MUCOADHESIVE POLYSACCHARIDES, ABLE TO STIMULATE CORNERAL RECOVERY
GB1340516A (en) Ophthalmic solution
GB1244809A (en) Synergistic antibacterial compositions
GB1113760A (en) Ophthalmic composition
ES438931A1 (en) Compositions for treatment of cardiovascular conditions associated with overproduction of catecholamines
ES8308215A1 (en) A soft contactlens preserving composition.
KR0143509B1 (en) Topical composition
GB1180615A (en) Novel Substituted Hexahydroazepino-(4,5-b) Indoles
JPH0717863A (en) Pranoprofen eye drops
GB1333906A (en) Pharmaceutical compositions
ES8502337A1 (en) Gel-form antimycotic compositions for treating fungal infections of the buccal cavity.
US3415929A (en) Ophthalmic solution containing poly-1,3-beta-glucoside
JPH1025254A (en) Water-soluble preparation free from contraindication
JPS5762218A (en) Ophthalmic solution
US3044937A (en) Process and composition for examining eyes with fluorescent vitamin b
GB797237A (en) Composition for reducing period of anesthesia
GB536247A (en) Improvements in aerosols particularly those having germicidal, disinfecting, insecticidal, or medicinal qualities
ES253169A3 (en) Method for obtaining solubilized adrenocrome compositions (Machine-translation by Google Translate, not legally binding)
ES8604246A1 (en) alpha-acyloximino-alkane-phosphonic(and -phosphinic) acid esters, their preparation and their use in plant protection.
GB1320316A (en) Ophthalmic compositions
ES356078A1 (en) Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid.
ES460319A1 (en) Derivatives of quinoxaline-1,4-dioxides
GB549133A (en) Improvements connected with lawn mowers
GR3018349T3 (en) Use of naproxen as mydriatic agent.